EICHOR
● Completed
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Condition: HSV Infection · Sponsor: AiCuris Anti-infective Cures AG
About this study
Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or acyclovir susceptible mucocutaneous HSV infection, treated with pritelivir 100 mg once daily (following a loading dose of 400 mg as first dose to rapidly reach steady-state plasma concentration) or investigators choice, which can be either foscarnet 40 mg/kg every 8 hours or 60 mg/kg every 12 hours, or Cidofovir iv 5 mg/kg body weight given once weekly, or Cidofovir 1% or 3% topical applied 2 to 4 times daily, or Imiquimod 5% topical 3 times per week) (provided the drug is nationally approved).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (70)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Metro Infectious Disease Consultants, LLC - Huntsville | Huntsville, Alabama, United States | — |
| University of South Alabama | Mobile, Alabama, United States | — |
| University Arizona - Department of Medicine Arizona Health Sciences Center | Tucson, Arizona, United States | — |
| City of Hope | Duarte, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| University of California, Division of Infectious Diseases | Sacramento, California, United States | — |
| Midland Florida Clinical Research Center, LLC | DeLand, Florida, United States | — |
| Midway Immunology and Research Center (MIRC) | Ft. Pierce, Florida, United States | — |
| University of Florida (UF) - Division of Infectious Disease | Gainesville, Florida, United States | — |
| Links Clinical Trials | Miami, Florida, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
+ 58 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03073967